Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Predictors of Religious Orientation Attitudes in Menopausal Women (MENO-RO)

26 augusti 2026 uppdaterad av: Aslıhan Turan, KTO Karatay University

Predictors of Attitudes Toward Religious Orientation in Menopausal Women: A Cross-Sectional Study

This descriptive, cross-sectional study examines whether the severity of menopausal symptoms and attitudes toward sexual myths predict intrinsic religious orientation in menopausal women. Menopause is a multidimensional transition with biological, psychological, social and spiritual aspects, and in societies with a strong cultural and religious fabric women may draw on religious orientation as a coping and meaning-making resource. Participants are healthy women aged 49 to 59 with a diagnosis of menopause and no chronic disease, recruited in Konya, Turkey. Data are collected face to face using a personal information form, the Menopause Rating Scale, the Intrinsic Religious Orientation Scale and the Sexual Myths Scale, and analysed with multiple regression.

Studieöversikt

Status

Rekrytering

Detaljerad beskrivning

Background:

Menopause is a multidimensional transition in a woman's life with biological, psychological, social and spiritual dimensions. With increasing life expectancy, women spend roughly a third of their lives in the menopausal period. The decline in oestrogen is associated with hot flushes, sleep disturbance, mood fluctuations and sexual dysfunction, which can adversely affect quality of life. The literature emphasises that the menopause experience is shaped not only biologically but also by sociocultural factors and religious beliefs, and that religious and spiritual orientation can increase psychological resilience and reduce anxiety and stress. Sexual dysfunction is highly prevalent in this period, and sexuality is closely linked to lifestyle, cultural roles, religious beliefs and societal myths; low sexual awareness and adoption of sexual myths may intensify the perceived severity of menopausal symptoms.

Aim:

To determine the predictive effect of the physical and psychological symptoms of menopause and of attitudes toward sexual myths on the intrinsic religious orientation of menopausal women.

Design and setting:

Descriptive, cross-sectional design. The study population comprises healthy women aged 49 to 59 with a diagnosis of menopause and no chronic health problem, presenting to a health facility in Konya, Turkey. The sample consists of women who meet the inclusion criteria and volunteer to participate.

Sample size:

Calculated with G*Power 3. For a linear multiple regression model with a medium effect size of 0.15, power of 0.95 and a Type I error of 0.05, a minimum of 89 participants is required. Allowing for a possible 10 percent data loss, 97 participants are planned.

Measures:

A personal information form (15 items covering sociodemographic and obstetric characteristics), the Menopause Rating Scale (MRS), the Intrinsic Religious Orientation Scale and the Sexual Myths Scale. Written informed consent is obtained; author permissions for the scales are obtained by email. Data are collected face to face.

Statistical analysis:

Analyses are performed with IBM SPSS Statistics v29.0. Normality is assessed with visual and analytical methods (Kolmogorov-Smirnov test). Descriptive statistics are reported as mean and standard deviation or median (minimum to maximum) as appropriate. Multiple regression models are built to estimate regression coefficients and 95 percent confidence intervals for the relationships between religious orientation and age, number of pregnancies, menopause duration, menopause symptom severity and sexual myths. Group comparisons use the Mann-Whitney U and Kruskal-Wallis tests where appropriate. Significance is set at p less than 0.05.

Ethics:

Institutional permission and ethics approval will be obtained from the Non-Drug and Non-Medical Device Research Ethics Board of KTO Karatay University before the study begins. Written informed consent is obtained from all participants.

Studietyp

Observationell

Inskrivning (Beräknad)

97

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studiekontakt

Studieorter

      • Konya, Turkiet (Türkiye)
        • Rekrytering
        • Recruitment site (to be specified), Konya
        • Kontakt:
          • Aslihan Turan
        • Huvudutredare:
          • Aslihan Turan

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

  • Vuxen

Tar emot friska volontärer

Ja

Testmetod

Icke-sannolikhetsprov

Studera befolkning

Healthy women aged 49 to 59 with a diagnosis of menopause and no chronic health problem, presenting to a health facility in Konya, Turkey, who volunteer and provide written informed consent.

Beskrivning

Inclusion Criteria:

  • Woman aged 49 to 59 years
  • Diagnosis of menopause
  • No chronic health problem
  • Volunteers to participate and provides written informed consent

Exclusion Criteria:

* Presence of a chronic disease (e.g. cardiac disease, diabetes, hypertension)

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

Kohorter och interventioner

Grupp / Kohort
Menopausal women aged 49 to 59
Healthy women aged 49 to 59 with a diagnosis of menopause and no chronic disease (such as cardiac disease, diabetes or hypertension), recruited in Konya, Turkey, who volunteer to participate. Participants complete a single battery of self-report scales collected face to face; no intervention is applied.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Intrinsic religious orientation (Intrinsic Religious Orientation Scale)
Tidsram: Single assessment at enrollment (Day 1)
The Intrinsic Religious Orientation Scale (Hoge, 1972; Turkish standardisation by Karaca, 2001) contains 10 items measuring intrinsic religious motivation. Seven items are positively worded and three are negatively worded and reverse coded. Items are rated on a 5-point Likert format scored from 0 (weakest) to 4 (strongest), giving a total score of 0 to 40, with higher scores indicating stronger intrinsic religious orientation.
Single assessment at enrollment (Day 1)

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Menopausal symptom severity (Menopause Rating Scale, MRS)
Tidsram: Single assessment at enrollment (Day 1)
The Menopause Rating Scale (Schneider et al., 2000; Turkish adaptation by Can Gurkan, 2005) is an 11-item scale with three subscales: somatic complaints, psychological complaints and urogenital complaints. Each item is rated on a 5-point scale from 0 (none) to 4 (very severe), giving a total score of 0 to 44, with higher scores indicating greater symptom severity.
Single assessment at enrollment (Day 1)
Sexual myths (Sexual Myths Scale, SMS)
Tidsram: Single assessment at enrollment (Day 1)
The Sexual Myths Scale (Golbasi et al., 2016) is a 28-item, 5-point Likert scale with eight subscales (sexual orientation, gender, age and sexuality, sexual behaviour, masturbation, sexual violence, sexual intercourse and sexual satisfaction). The total score ranges from 28 to 140, with higher scores indicating a greater likelihood of holding sexual myths.
Single assessment at enrollment (Day 1)

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Utredare

  • Huvudutredare: Aslihan Turan, KTO Karatay University

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

26 augusti 2026

Primärt slutförande (Beräknad)

1 februari 2027

Avslutad studie (Beräknad)

2 februari 2027

Studieregistreringsdatum

Först inskickad

26 augusti 2026

Först inskickad som uppfyllde QC-kriterierna

26 augusti 2026

Första postat (Faktisk)

1 september 2026

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

1 september 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

26 augusti 2026

Senast verifierad

1 augusti 2026

Mer information

Termer relaterade till denna studie

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

NEJ

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera